Halo Pharmaceutical Articles
Halo names George Bobotas as CSO in deal with DeMelle
23 April 2009
Halo completes purchase of Abbott NJ facility
12 January 2009
Showing 1-2 of 2 articles
- 1
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
